Obstetric antiphospholipid syndrome: early variations of angiogenic factors are associated with adverse outcomes.

Cochery-Nouvellon, Éva

Obstetric antiphospholipid syndrome: early variations of angiogenic factors are associated with adverse outcomes. [electronic resource] - Haematologica 05 2017 - 835-842 p. digital

Publication Type: Clinical Trial; Journal Article; Observational Study

1592-8721

10.3324/haematol.2016.155184 doi


Adolescent
Adult
Antiphospholipid Syndrome--blood
Aspirin--therapeutic use
Female
Fibrinolytic Agents--therapeutic use
Heparin, Low-Molecular-Weight--therapeutic use
Humans
Membrane Proteins--blood
Placenta--metabolism
Pregnancy
Pregnancy Complications--blood
Pregnancy Outcome
Pregnancy Trimester, First--blood
Vascular Endothelial Growth Factor Receptor-1--blood
Young Adult